Pause in Trading
Open PDF
| Stock | Neuren Pharmaceuticals Ltd (NEU.ASX) |
|---|---|
| Release Time | 4 Feb 2026, 9:57 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Neuren Pharmaceuticals Pauses Trading
Key Points
- Trading in Neuren Pharmaceuticals' securities temporarily paused
- Pending further announcement from the company
- Reason for trading pause not specified
Full Summary
Neuren Pharmaceuticals Ltd, a biopharmaceutical company, has announced that trading in its securities will be temporarily paused on the Australian Securities Exchange (ASX). The announcement does not specify the reason for the trading pause, but states that it is pending a further announcement from the company. The trading pause was effective from the time of the announcement on February 4, 2026. No additional details or context were provided in the brief market release.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In